Register for OBR daily

Kantar Health Conference Sidebar

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

RNN $0.73 0.0680 +10.27%
IMNP $3.79 0.2900 +8.29%
MRTX $18.07 1.3200 +7.88%
CBMG $18.40 1.2850 +7.51%
MGNX $20.15 1.3000 +6.90%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

TGTX $8.26 -1.3350 -13.92%
VRML $2.37 -0.1300 -5.20%
GERN $2.59 -0.1300 -4.78%
CNDO $1.64 -0.0600 -3.53%
CTIC $2.66 -0.0800 -2.92%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

Sarepta Data Disappoints Wall Street as Expert Sees a Sea Change at FDA

(Forbes) July 10, 2014 - It may be one of the most-watched small studies in biotech history. This morning, Sarepta Therapeutics of Cambridge, Mass., released 144-week data from its study of eteplirsen, for Duchenne muscular dystrophy, in 12 boys.
read article 

The Cancer Tests You Really Need—And Those You Don't

(Consumer Reports) July 9, 2014 – Consumer Reports advice on mammograms, Pap tests, colonoscopy, and the PSA test.
read article 

USC's Keck Medicine Joins Trend to Combine Academic and Local Cancer Care

( July 9, 2014 - Keck Medicine of the University of Southern California completed its acquisition of Orange Coast Oncology Hematology Medical Associates in a move intended to extend the academic medical center's comprehensive cancer care to more convenient local settings.
read article 

Penn Mesothelioma Program Receives $8 Million NCI Grant to Study Effects of Photodynamic Therapy Plus Surgery on Patient Survival and Disease Progression

(Penn Medicine) July 10, 2014 - Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
read press release 

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostic Test For Cancer Treatment

(Ventana) July 10, 2014 - Ventana Medical Systems, Inc., a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays.
read corporate press release 

MELA Sciences Begins Insurance Reimbursement Process With Application for New CPT Code For the MelaFind System

(StreetInsider) July 10, 2014 - MELA Sciences, Inc., announced today that it has taken the first step in the process of seeking insurance reimbursement for its Multi-Spectral Digital Skin Lesion Analysis (MSDSLA) procedure that is performed by dermatologists utilizing the MelaFind system as an aid in the detection of melanoma.
read article 

Basilea's Partner Astellas Submits Isavuconazole U.S. NDA For the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

(MarketWatch) July 9, 2014 - Basilea Pharmaceutica Ltd. reports today that its co-development partner Astellas Pharma Inc. submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (zygomycosis).
read article 

Fox Chase Cancer Center Researchers Recommend Updating the ‘Staging Criteria’ for Breast Cancer Diagnoses

(Fox Chase) July 7, 2014 - New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond.
read press release 

Pancreatic Surgery Complications Impact Hospital Costs More Than Length of Stay

(UC Davis CCC) July 10, 2014 - When it comes to a specific type of pancreatic surgery, post-operative complications have a far greater impact on total cost than does how long the patient stays in the hospital, according to a published paper by UC Davis researchers.
read press release 

Largest Study of Consolidation Therapy For Ewing's Sarcoma

(Medscape Medical News) July 9, 2014 - As consolidation therapy for Ewing's sarcoma, there is little difference in the cure rate between cyclophosphamide and ifosfamide, new research shows.
read article (free registration required) 

New Target For Aggressive Bladder Cancer

(Cancer Research UK/Press Association) July 9, 2014 - An international team of scientists have discovered a faulty process in certain bladder cancers that could point to new ways to treat patients with an aggressive form of the disease.
read article 

Depressed Men With Prostate Cancer Fare Worse

(Doctors Lounge/HealthDay News) July 9, 2014 - Depressed men with a diagnosis of intermediate- or high-risk prostate cancer have worse overall outcomes, according to a study published online July 7 in the Journal of Clinical Oncology.
read article 

Vasectomy and Prostate Ca: How Serious the Link?

(MedPage Today) July 9, 2014 - Men who had a vasectomy had a significantly greater risk of developing aggressive, potentially fatal prostate cancer, according to data from a 50,000-patient cohort study.
read article (free registration required) 

Cancer Drug Finds New Use as Fertility Treatment

(USA Today) July 9, 2014 - New treatment regiment boosts pregnancy rates in women with common condition.
read article 

Breast Cancer Drug Aromasin May Be Option for Some Premenopausal Women

(U.S. News & World Report/HealthDay News) July 9, 2014 - The drug exemestane worked slightly better than the drug tamoxifen at preventing a recurrence of breast cancer in certain premenopausal women, according to a new study.
read article 

Study Identifies Novel Genomic Changes in the Most Common Type of Lung Cancer

(NIH) July 9, 2014 - Researchers from The Cancer Genome Atlas (TCGA) Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer.
read press release 

Bristol to Seek Melanoma Approval For Opdivo Ahead of Expectations

(Reuters) July 10, 2014 - Bristol-Myers Squibb Co said on Thursday it plans to seek U.S. marketing approval in the third quarter for its experimental cancer immunotherapy Opdivo as a treatment for advanced melanoma, which would be months sooner than Wall Street expected.
read article 

Lung Cancer Genomic Mapping Yields New Targets in Study

(Bloomberg) July 9, 2014 - Mutations within a small cluster of genes tied to tumor growth are involved in three-quarters of the cases of the most common form of lung cancer, according to a study that could help link treatment to specific genetic flaws.
read article 

Sanofi Sues Eli Lilly Over Insulin Rival to Lantus

(Reuters) July 8, 2014 - Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.
read article 

Smallpox Vials, Decades Old, Found in Storage Room at NIH Campus in Bethesda

(Washington Post) July 8, 2014 - A government scientist cleaning out a storage room last week at a lab on the National Institutes of Health’s Bethesda campus found decades-old vials of smallpox, the second incident involving the mishandling of a highly dangerous pathogen by a federal health agency in a month.
read article (free registration required) 

Health Care Innovation Awards to Provide Better Health Care and Lower Costs

( July 9, 2014 - Today, Health and Human Services Secretary Sylvia Mathews Burwell announced new prospective awardees to test innovative care models, bringing the total amount of funding to as much as $360 million for 39 recipients spanning 27 states and the District of Columbia.
read press release 

Servier to Teva Fined $583 Million on Generic-Drug Delays

(Bloomberg) July 9, 2014 - Les Laboratoires Servier and five makers of generic drugs, including Teva Pharmaceutical Industries Ltd., were fined 427.7 million euros ($582.2 million) by the European Union over agreements that delayed the release of cheaper versions of a hypertension treatment.
read article 

As Vital Generic-Drug Prices Soar, So Do Pharmaceuticals’ Profits

(TIME) July 9, 2014 - Patients are facing a sudden increase in costs for generic drugs, which is putting their health at risk, according to a report by the New York Times.
read article 

LUNGevity Foundation, Lung Cancer Research Foundation, and Melanoma Research Alliance Join Forces in First-Ever Research Collaboration

(LUNGevity Foundation) July 9, 2014 - LUNGevity Foundation today announced a partnership with the Lung Cancer Research Foundation and Melanoma Research Alliance to co-fund new innovative research on PD-1 inhibitor treatment options for both non-small cell lung cancer (NSCLC) and metastatic melanoma (MM) patients with brain metastases.
read press release 

MabVax Therapeutics and Telik Announce Closing of Merger

(Yahoo! Finance) July 9, 2014 - MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, and Telik, Inc., a publicly-traded clinical stage oncology drug development company, have finalized their merger initially announced on May 12th.
read article